A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis

Clinical trial NCT06909136 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06909136
Sponsor: Suzhou Junjing BioSciences Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly

Start date: 2025-07-28
Primary completion: 2027-10-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.